HTA: New Opportunity to Apply for Joint Scientific Consultations
On 1st April 2026, the European Commission will open the second requaest period for joint scientific consultations (JSCs) for 2026. The purpose of the JSCs are to provide both marers and pharmaceutical companies with an opportunity to consult
HTA Coordination Group publishes its 2025 Annual Report
In its 2025 Annual Report the Health Technology Assessment (HTA) confirmed that, in 2025, four joint scientific consultations were completed.
The Group also commenced 13 joint clinical assessments on new